A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer

Overview of attention for article published in Applied Health Economics and Health Policy, October 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 88 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Opdivo for Non-Small Cell Lung Cancer – Details

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.